Drug Profile
Ketamine/butamben topical - EpiCept
Alternative Names: EpiCept™NP-2; NP-2Latest Information Update: 13 May 2011
Price :
$50
*
At a glance
- Originator EpiCept Corporation
- Class Cyclohexanes; Local anaesthetics; Small molecules
- Mechanism of Action NMDA receptor antagonists; Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Neuropathic pain
Most Recent Events
- 13 May 2011 Discontinued - Phase-I/II for Neuropathic pain in USA (Topical)
- 07 Jun 2005 Phase-I/II clinical trials in Neuropathic pain in USA (Topical)
- 17 Mar 2003 Preclinical trials in Neuropathic pain in USA (Topical)